SCHEMBL23958170

SCHEMBL23958170

COc1cc(Nc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
PIK3CG P48736 4/20 0.41
PI4KA P42356 3/20 0.41
PIK3CD O00329 1/20 0.41
PIK3C3 Q8NEB9 1/20 0.41
TDO2 P48775 1/20 0.40
IDO2 Q6ZQW0 1/20 0.40
PNP P00491 1/20 0.40
HTR7 P34969 3/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2C P28335 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958146 0.87 TDO2 (0.45) POLBPIK3CGPIK3CDPIK3C3TDO2
SCHEMBL23931388 0.86 TDO2 (0.44) POLBPIK3CGPI4KAPIK3CDPIK3C3
SCHEMBL30103205 0.86 TDO2 (0.44) POLBPIK3CGPI4KAPIK3CDPIK3C3
SCHEMBL23958194 0.83 TDO2 (0.46) POLBPIK3CGPIK3CDPIK3C3TDO2
SCHEMBL29623155 0.83 TDO2 (0.50) POLBPIK3CGPIK3CDPIK3C3TDO2
SCHEMBL23045334 0.83 TDO2 (0.50) POLBPIK3CGPIK3CDPIK3C3TDO2
SCHEMBL23958159 0.82 HTR7 (0.45) POLBPIK3CGPI4KAPIK3CDPIK3C3
SCHEMBL24111027 0.82 HTR7 (0.42) POLBPIK3CGPI4KAPIK3CDPIK3C3
SCHEMBL23958160 0.82 PIK3CG (0.45) POLBPIK3CGPI4KAPIK3CDPIK3C3
SCHEMBL24110949 0.81 HTR7 (0.44) POLBPIK3CGPI4KATDO2IDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 POLB 4618/4885PIK3CG 3250/4885PI4KA 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.